Company Information

  

Address: 3579 VALLEY CENTRE DRIVE  
City: SAN DIEGO 
State: CA 
Zip Code: 92130 
Telephone: 804-827-2524 

Description of Business

Primary SIC Code: 2836
(As filed with the SEC)  

We are a biotechnology company pioneering the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. Phages have powerful and highly selective mechanisms of action that permit them to bind to and kill specific bacteria. We believe that phages represent a promising means to treat bacterial infections, especially those that have developed resistance to current therapies, including the so-called multi-drug-resistant or "superbug" strains of bacteria. The extensive use of antibiotics since the beginning of the modern antibiotics era in the 1940s has resulted in drug resistance among many disease-causing bacteria. According to the U.S. Centers for Disease Control and Prevention, or CDC, resistance to antibiotics threatens to reverse many of the key medical advances of the last half-century.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
03/2018-0.31NAN/E
12/2017-2.18NAN/E
09/2017-9.16NAN/E
06/2017-11.83NAN/E
03/2017-184.20NAN/E
12/2016-247.00NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.03Total Liab/Total Assets0.31
Net Inc/Total Assets-1.15Total Liab/Inv Cap0.37
Net Inc/Inv Cap-1.40Total Liab/Comm Equity0.01
Pretax Inc/Net Sales-122.96Interest Coverage RatioNA
Net Inc/Net Sales-111.63Curr Debt/EquityNA
Cash Flow/Net Sales-79.93LTD/Equity0.04
SG&A/NetSales66.00Total Debt/Equity0.04
Asset Utilization   Liquidity  
Net Receivables TurnoverNAQuick Ratio2.74
Inventory TurnoverNACurrent Ratio2.74
Inventory Day SalesNANet Rec/Curr AssetsNA
Net Sales/Work Cap0.03Inv/Curr AssetsNA
Net Sales/PP&E0.14  

Income Statement (Millions)

  3/31/2018 12/31/2017 9/30/2017 6/30/2017
Total Revenues(Net Sales) 0.00 0.02 0.04 0.03
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 1.59 1.30 1.61 2.78
Operating Income -3.06 -2.37 -0.75 -9.69
Interest Exp NA NA NA NA
Pretax Income -3.13 -2.35 -0.78 -7.76
Other Income -0.08 0.01 -0.03 1.92
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -3.13 -2.35 -0.78 -6.46

Balance Sheet (Millions)

Assets 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Cash & Short Term Investments 8.21 5.13 7.73 8.96
Receivables - Total NA NA 0.00 0.00
Inventories - Total NA NA NA NA
Total Current Assets 8.74 5.39 7.99 9.24
Net Property, Plant & Equipment 0.73 0.82 0.85 0.91
Total Assets 14.40 11.14 13.78 15.11
Liabilities        
Accounts Payable 1.78 1.97 2.13 2.97
Debt in Current Liabilities NA 0.00 0.31 0.61
Total Current Liabilities 1.78 1.97 2.48 3.71
Long-Term Debt 0.19 0.29 0.40 0.39
Total Liabilities 3.11 3.41 4.02 5.25
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 0.17 0.10 0.09 0.09
Retained Earnings -397.34 -394.21 -391.85 -391.08
Treasury Stock NA NA NA NA
Total Stockholders' Equity 11.29 7.73 9.76 9.86
Total Liabilities and Stockholders' Equity 14.40 11.14 13.78 15.11

Cash Flow Summary (Millions)

Categories 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Net Cash Provided by Operating Activities -3.54 -2.37 -0.59 -2.93
Net Cash Provided by Investing Activities 0.00 -0.02 -0.03 -0.00
Net Cash Provided by Financing Activities 6.61 -0.21 -0.61 9.69

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20130.08-64.58--
12/20140.4123.11--
12/20150.48-0.52--
12/20160.26-18.84-247.00
12/20170.12-12.84-2.18
Growth Rates9.16----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/18281,3818.37




Report Date : 7/9/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.